miRNA-186-5p在乳腺癌中的研究进展

MRP

Medical Research and Practice

2993-96902993-9704

Art and Design

10.61369/MRP.2025040016

Article

miRNA-186-5p在乳腺癌中的研究进展https://artdesignp.com/journal/MRP/3/4/10.61369/MRP.2025040016罗鹏,杨林,王炳胜

2025

2025-04-20

    随着对miRNA以及乳腺癌研究深入，人们发现miRNA在乳腺癌的分子分型、发生、发展、治疗等各个方面起到关键作用。MiRNA-186    是一种重要的    miRNA，通过差异性表达，参与各种癌症的细胞增殖、凋亡、迁移和侵袭。但其在乳腺癌中的报道较少，本文就miRNA-186-5p在乳腺癌中的作用做一下总结，并提出一些miRNA-186-5p在乳腺癌中潜在的机制，希望其可能成为乳腺癌预后指标和治疗的靶向目标。乳腺癌,miRNA-186-5p,耐药,免疫,靶向治疗

1]Zhihui, J.; Jia, Y.; Sen, C.; Yijun, R.; Weichun, G., CircDOCK1 Regulates miRNA-186/DNMT3A to Promote Osteosarcoma Progression. Biomedicines 2022, 10 (12). [2]Qianjin, Z.; Lin, H.; Zhiyong, S.; Fengye, W.; Conghui, H., MiRNA-186-5p suppresses cell migration, invasion, and epithelial mesenchymal transition in bladder cancer by targeting RAB27A/B. Environ Toxicol 2021, 36 (11). [3]Wang, Z.;  Sha, H. H.; Li, H. J., Functions and mechanisms of miRNA-186 in human cancer. Biomed Pharmacother 2019, 119, 109428. [4]X, L.;  X, Z.;  Y, C.;  Y, H.;  J, H.; H, L., miRNA-186-5p targeting SIX1 inhibits cisplatin resistance in non-small-cell lung cancer cells (NSCLCs). Neoplasma 2019, 67 (1). [5]Vivien, B.;  Xu, Y.;  Anne S, B.;  Emmanuel, A.;  Elke, E.;  Johannes, H.;  Rainer M, B.;  Eckart, M.;  Yingjun, Z.;  Michael D, M.;  Matthias W, L.; Yuan, G., Hypoxia-induced downregulation of microRNA-186-5p in endothelial cells promotes non-small cell lung cancer angiogenesis by upregulating protein kinase C alpha. Mol Ther Nucleic Acids 2023, 31 (0). [6]Liu, Y.;  Jiang, Y.;  Xu, L.;  Qu, C.;  Zhang, L.;  Xiao, X.;  Chen, W.;  Li, K.;  Liang, Q.; Wu, H., circ-NRIP1 Promotes Glycolysis and Tumor Progression by Regulating miRNA-186-5p/MYH9 Axis in Gastric Cancer. Cancer Manag Res 2020, 12, 5945-5956. [7]Shan, Y.; Li, P., Long Intergenic Non-Protein Coding RNA 665 Regulates Viability, Apoptosis, and Autophagy via the MiRNA-186-5p/MAP4K3 Axis in Hepatocellular Carcinoma. Yonsei Med J 2019, 60 (9), 842-853.